Evidence map›Paper›PMID 42153129›Full record

ReviewContact (Thousand Oaks (Ventura County, Calif.))

Genetically Encoded Tools to Monitor and Interrogate Membrane Contact Sites.

Yuepeng Ke, Tien-Hung Lan, Thomas Ahn, Yubin Zhou

Abstract readReview
In one paragraph

Review in Contact (Thousand Oaks (Ventura County, Calif.)). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuepeng KeCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA.
Tien-Hung LanCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA.
Thomas AhnCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA.
Yubin ZhouCenter for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA.ORCID https://orcid.org/0000-0001-7962-0517

Funding

Engineering Smart Antibody-like Protein Scaffolds with precision switchesR01GM144986 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ZHOU, YUBIN · 2022 to 2025
$1.3M
Molecular control of calcium signaling at membrane contact sitesR35GM163674 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Yubin Zhou · 2026 to 2026
$419k
Synthetic biology toolkit for precise tuning of T cell activityR21AI174606 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ZHOU, YUBIN · 2023 to 2024
$417k
NIAID NIH HHS R21 AI174606NIGMS NIH HHS R01 GM144986NIGMS NIH HHS R35 GM163674
6 · The paper itself

Abstract

Membrane contact sites (MCSs) are dynamic subcellular compartments formed between organelles that coordinate diverse aspects of cellular communication, including signaling, metabolism, and membrane organization. Tools capable of monitoring and controlling the spatially localized and dynamic properties of MCSs are needed to dissect their regulatory mechanisms and physiological roles. Recent advances in protein engineering have begun to address this need. Proximity-based reporters, chemogenetic approaches, and optogenetic systems have been developed to enable the visualization, interrogation, and manipulation of inter-organelle contacts with improved spatial and temporal precision. This minireview highlights key developments in these molecular toolkits and their representative applications in studying MCS biology. These approaches provide new insights into organelle crosstalk and may inform future therapeutic strategies targeting MCSs.

Indexed as

cellsignalingchemically induced proximitychemogeneticsmembrane contact sties (MCSs)optogeneticsproximity-based labeling

Identifiers

PMID42153129
PMCPMC13180065

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.